New immunotherapy drug Keytruda approved by FDA to fight 'tough-to-treat' breast cancer

Keytruda, developed by Merck & Co Inc, has been given FDA approval to be used to combat TNBC. The rare form of breast cancer appears in 10 to 15 percent of women who are diagnosed.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news